DAWN Day One Biopharmaceuticals

Watchlist

12.210
-0.300-2.40%

Close Jan 24 16:00 ET

12.210
0.0000.00%

Post 16:53 ET

1.23BMarket Cap-12.59P/E (TTM)

About Day One Biopharmaceuticals Company

Day One Biopharmaceuticals, Inc. operates as a holding company. The firm through its subsidiary develops and commercializes targeted therapies for patients of all ages with genetically defined cancers. Its products include DAY101 and pimsertib. The company was founded by Julie Grant and Samuel Blackman in November 2018 and is headquartered in Brisbane, CA.

Company Profile

SymbolDAWN

Company NameDay One Biopharmaceuticals

Listing DateMay 27, 2021

Issue Price16.00

Founded2018

CEODr. Jeremy Bender

MarketNASDAQ

Employees155

Fiscal Year Ends12-31

Address2000 Sierra Point Parkway,Suite 501

CityBrisbane

ProvinceCalifornia

CountryUnited States of America

Zip Code94005

Phone1-650-484-0899

Websitehttp://www.dayonebio.com

Company Executives

Name
Position
Salary

Dr. Jeremy Bender
Chief Executive Officer, President and Director
6.91M

Adam Dubow
General Counsel and Chief Compliance Officer
2.77M

Charles N. York, II
Principal Accounting Officer, Chief Operating Officer, Chief Financial Officer and Secretary
3.55M

Garry A. Nicholson
Chairman of the Board
383.38K

Habib Joseph Dable
Director
--

Dr. William Grossman
Director
--

Saira Ramasastry, M.Phil,M.S.
Independent Director
351.75K

Michael Gladstone
Independent Director
342.88K

Dr. John A. Josey, PhD
Independent Director
350.75K

Natalie C. Holles
Lead Independent Director
352.50K

Scott Garland
Independent Director
342.88K

Dr. Samuel Blackman, M.D.
Head of Research and Development
2.49M

DAWN Day One Biopharmaceuticals

About Day One Biopharmaceuticals Company

Company Profile

Company Executives

Trending Stocks